Catalyst Wire Dossier Catalyst Wire Dossier

oral vinorelbine

vinorelbine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for oral vinorelbine, covering 2023-02-28 to 2023-02-28. Get the full timeline:

Most recent: Clinical Trial Update: Oral Vinorelbine and Capecitabine in Advanced HER2-negative Breast Cancer [Phase 2]

See pricing